Vote Scores

Home / Companies / Jazz Pharmaceuticals plc / 24 Jul 2025

Meeting · year to 30 June 2026719 filers reporting

Jazz Pharmaceuticals plc: meeting of 24 Jul 2025

Votes reported on Form N-PX, item by item

719 Form N-PX filers reported votes at the Jazz Pharmaceuticals plc meeting of 24 Jul 2025. Their records fall into 4 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.

foragainstabstain, withhold or otheramber tick: the portion cast against management

Items

1

DIRECTOR ELECTIONSIssuer

Director elections

4 nominees; 93.5% of reported votes for; 31 filers withheld from or voted against at least one nominee.

1,914 vote records from 211 filers. 9 of the 211 filers that marked the item either way voted against management.

95.7% for3.8% against0.5% other4.3% against management211 filers
2

SECTION 14A SAY-ON-PAY VOTESIssuer

Advisory vote on executive pay (say-on-pay)

1,133 vote records from 715 filers. 42 of the 685 filers that marked the item either way voted against management. 30 filers reported this item without a management mark.

89.5% for5.5% against5.0% other6.1% against management715 filers95.8% for3.9% against0.3% other4.2% against management64,488,413 reported shares
3

AUDIT-RELATEDIssuer

Audit-related items (auditor ratification)

478 vote records from 210 filers. 3 of the 210 filers that marked the item either way voted against management.

98.6% for1.0% against0.5% other1.4% against management210 filers99.5% for0.5% against0.0% other0.5% against management25,379,307 reported shares
4

CAPITAL STRUCTUREIssuer

CAPITAL STRUCTURE: management items

Management items in this category are shown together; filers word and number them differently.

478 vote records from 209 filers. 4 of the 209 filers that marked the item either way voted against management.

98.1% for1.9% against1.9% against management209 filers99.7% for0.3% against0.3% against management25,357,650 reported shares, counted once per item in this group

How the largest families voted

Family1. Directors2. Say-on-pay3. Auditor
VanguardForForFor
BlackRock and iSharesForForFor
FidelityForForFor
DimensionalForForFor
State Street and SPDRForForFor
American CenturyForAgainst *For
Franklin TempletonForForFor
InvescoForForFor
EquitableAgainst *ForFor
Charles SchwabForForFor
Nuveen and TIAAForForFor
ProShares and ProFundsForForFor
John Hancock and ManulifeForForFor
Morgan Stanley, Eaton Vance and CalvertAgainst *ForFor
J.P. MorganForForFor
Goldman SachsForForFor
WisdomTreeForForFor
PGIM and PrudentialForForFor
Jackson National fundsForForFor
Northern Trust and FlexSharesForForFor
SEIForForFor
T. Rowe PriceForForFor
ThriventForForFor
Lincoln FinancialForForFor
VoyaForForFor
First TrustForForFor
Russell InvestmentsForForFor
NationwideForForFor
Victory CapitalForForFor
Brighthouse FundsForForFor
Guggenheim and RydexForForFor
Columbia ThreadneedleForForFor
BNY MellonForForFor
PrincipalForForFor
Capital Group and American FundsForForFor
Pacific Life fundsForForFor
Global XNo reportForNo report
MFSForForFor
TransamericaForForFor
Federated HermesForForFor
AllianceBernsteinNo reportForNo report
DWSForForFor
PIMCOForForFor
AllspringForForFor
MassMutualForForFor
Harbor FundsForForFor
VirtusForForFor
VanEckForForFor
Neuberger BermanNo reportForNo report
American BeaconForForFor
Natixis and Loomis SaylesForForFor
BairdNo reportForNo report

* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.

Questions

How did large funds vote at the Jazz Pharmaceuticals plc meeting?

719 Form N-PX filers reported votes at the meeting of 24 Jul 2025. On say-on-pay, 42 of 685 voted against management (6.1%). The family table lists each of the largest families item by item.

Is this the meeting result?

No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by Jazz Pharmaceuticals plc on Form 8-K.

Why are director elections shown as counts only?

Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.

Every meeting on file for Jazz Pharmaceuticals plc

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing Jazz Pharmaceuticals plc with a meeting date within three days of 24 Jul 2025. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 23 Sep 2026.